Unique signal transduction of the VEGF family members VEGF-A and VEGF-E

Biochemical Society Transactions

Volumn 37, Issue 6, 2009, Pages 1161-1166

  Shibuya, Masabumi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JOBU UNIVERSITY   (Japan)

Author keywords

Angiogenic therapy; Oedema; Vascular endothelial growth factor (VEGF); Vascular endothelial growth factor E (VEGF E); Vascular endothelial growth factor receptor 1 (VEGFR 1)

Indexed keywords

CYTOKERATIN 14; SNAKE VENOM; VASCULOTROPIN A; VASCULOTROPIN E; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL LINEAGE; CELL PROLIFERATION; EDEMA; ENDOTHELIUM CELL; INFLAMMATION; ISCHEMIA; LYMPHANGIOGENESIS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CROTALID VENOMS; HUMANS; INFLAMMATION; KERATIN-14; LYMPHANGIOGENESIS; MACROPHAGES; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VIRAL PROTEINS;

MUS; MUS MUSCULUS; ORF VIRUS;

EID: 70450205064     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371161     Document Type: Article

References (36)

1. Risau, W. (1997) Mechanism of angiogenesis. Nature 386, 671-674
2. Ferrara, N. (2002) VEGF and the quest for tumour angiogenesis factors. Nat. Rev Cancer 2, 795-803
3. Shibuya, M. and Claesson-Welsh, L. (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312, 549-560
4. Carmellet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kleckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C. et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439
5. Alitalo, K. and Carmeliet, P. (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1, 219-227
6. Takahashi, T., Ueno, H. and Shibuya, M. (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18, 2221-2230
7. Sasaki, A., Taketomi, T., Kato, R., Saeki, K., Nonami, A., Sasaki, M., Kuriyama, M., Saito, N., Shibuya, M. and Yoshimura, A. (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat. Cell Biol. 5, 427-432
8. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. and Heldin, C.-H. (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995
9. Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, T. and Shibuya, M. (1996) Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor (PlGF), which is related to vascular endothelial growth factor (VEGF). Cell Growth Diff. 7, 213-221
10. Takahashi, T., Yamaguchi, S., Chida, K. and Shibuya, M. (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768-2778
11. Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N. and Shibuya, M. (2005) Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 102, 1076-1081
12. Lyttle, D.J., Fraser, K.M., Fleming, S.B., Mercer, A.A. and Robinson, A.J. (1994) Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol. 68, 84-92
13. Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y. and Shibuya, M. (1998) A novel type of vascular endothelial growth factor: VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 273, 31273-31282
14. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, HG., Ziche, M., Lanz, C., Buttner, M., Rziha, HJ. and Dehio, C. (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 18, 363-374
15. Wise, L.M., Veikkola, T., Mercer, A.A., Savory, L.J., Fleming, S.B., Caesar, C., Vitali, A., Makinen, T., Alitalo, K. and Stacker, SA. (1999) Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl. Acad. Sci. U.S.A. 96, 3071-3076
16. Mercer, A.A., Wise, L.M., Scagliarini, A., McInnes, C.J., Buttner, M., Rziha, H.J., McCaughan, C.A., Fleming, S.B., Ueda, N. and Nettleton, PF. (2002) Vascular endothelial growth factors encoded by Orf virus show surprising sequence variation but have a conserved, functionally relevant structure. J. Gen. Virol. 83, 2845-2855
17. Keyt, B.A., Nguyen, H.V., Berleau, L.T., Duarte, C.M., Park, J., Chen, H. and Ferrara, N. (1996) Identification of vascular endothelial growth factor determinanats for binding KDR and FLT-1 receptors. J. Biol. Chem. 271, 5638-5646
18. Kiba, A., Yabana, N. and Shibuya, M. (2003) A set of loop-1 and -3 structures in the novel VEGF family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling. J. Biol. Chem. 278, 13453-13461
19. Pieren, M., Prota, A.E., Ruch, C., Kostrewa, D., Wagner, A., Biedermann, K., Winkler, F.K. and Ballmer-Hofer, K. (2006) Crystal structure of the Orf virus NZ2 variant of vascular endothelial growth factor-E: implications for receptor specificity. J. Biol. Chem. 281, 19578-19587
20. Kiba, A., Sagara, H., Hara, T. and Shibuya, M. (2003) VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochem. Biophys. Res. Commun. 301, 371-377
21. Larcher, F., Murillas, R., Bolontrade, M., Conti, C.J. and Jorcano, J.L. (1998) VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17, 303-311
22. Detmar, M., Brown, L.F., Schon, M.P., Elicker, B.M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K.P. and Jain, R.K. (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111, 1-6
23. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T.N., Yancopoulos, G.D. and McDonald, D.M. (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511-2514
24. NZ7/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation. Arterioscler. Thromb. Vasc. Biol. 26, 2019-2026
25. Murakami, M., Zheng, Y., Hirashima, M., Suda, T., Morita, Y., Ooehara, J., Ema, H., Fong, G.H. and Shibuya, M. (2008) VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment. Arterioscler. Thromb. Vasc. Biol. 28, 658-664
26. Takahashi, H., Hattori, S., Iwamatsu, A., Takizawa, H. and Shibuya, M. (2004) A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. J. Biol. Chem. 279, 46304-46314
27. Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Martovani, A. and Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343
28. Clauss, M., Weich, H., Breier, G., Knies, U., Röckl, W., Waltenberger, J. and Risau, W. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J. Biol. Chem. 271, 17629-17634
29. Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T. and Shibuya, M. (2001) Vascular endothelial growth factor receptor-1 (Flt-1) is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97, 785-791
30. Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y. and Shibuya, M. (2006) Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocyte/macrophages. Blood 108, 1849-1856
31. Watari, K., Nakao, S., Fotovati, A., Basaki, Y., Hosoi, F., Bereczky, B., Higuchi, R., Miyamoto, T., Kuwano, M. and Ono, M. (2008) Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-κB activation. Biochem. Biophys. Res. Commun. 377, 826-831
32. Schoppmann, S.F., Fenzl, A., Nagy, K., Unger, S., Bayer, G., Geleff, S., Gnant, M., Horvat, R., Jakesz, R. and Birner, P. (2006) VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139, 839-846
33. Inoue, N., Kondo, T., Kobayashi, K., Aoki, M., Numaguchi, Y., Shibuya, M. and Murohara, T. (2007) Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arterioscler. Thromb. Vasc. Biol. 27, 99-105
34. NZ7/PlGF specifically binding to VEGFR-2 accelerates skin wound healing via enhancement of neovascularization. Arterioscler. Thromb. Vasc. Biol. 27, 503-511
35. Cho, C.H., Kim, K.E., Byun, J., Jang, H.S., Kim, D.K., Baluk, P., Baffert, F., Lee, G.M., Mochizuki, N., Kim, J. et al. (2005) Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ. Res. 97, 86-94
36. Azuma, J., Taniyama, Y., Takeya, Y., Iekushi, K., Aoki, M., Dosaka, N., Matsumoto, K., Nakamura, T., Ogihara, T. and Morishita, R. (2006) Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther. 13, 1206-1213